Related Experiment Video
Updated: Nov 11, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
miR-93-5p promotes insulin resistance to regulate type 2 diabetes progression in HepG2 cells by targeting HGF
Man Zhou1, Yilin Hou1, Jun Wu1
1Department of Endocrinology, Wuhan Third Hospital, Wuhan, Hubei 430060, P.R. China.
Abstract:
Insulin resistance is a common feature of type 2 diabetes mellitus (T2DM). However, the mechanisms underlying insulin resistance are not completely understood. The present study aimed to investigate the effect of microRNA (miR)‑93‑5p on insulin resistance in T2DM cells. Human hepatocellular carcinoma (HCC; HepG2) cells were cultured in medium with high glucose content (30 mM glucose) to establish an in vitro insulin‑resistant cell model (IR group). Glucose consumption and glycogen synthesis assays were performed to assess glucose consumption and glycogen synthesis, respectively. By performing immunoprecipitation assays, the abundance of the Met‑insulin receptor complex was detected in HepG2 cells. miR‑93‑5p and hepatocyte growth factor (HGF) mRNA expression levels were measured via reverse transcription‑quantitative PCR, and HGF protein expression levels were measured via western blotting. A dual‑luciferase reporter assay was conducted to investigate the interaction between miR‑93‑5p and HGF. Cell Counting Kit‑8, BrdU and caspase‑3 activity assays were performed to evaluate cell viability, proliferation and apoptosis, respectively, in insulin‑resistant HepG2 cells following transfection with small interfering RNA‑HGF, HGF overexpression vector, miR‑93‑5p mimic or miR‑93‑5p inhibitor. The results demonstrated that miR‑93‑5p expression was significantly increased and HGF expression was significantly decreased in HCC tissues isolated from patients with or without T2DM compared with adjacent healthy tissues isolated from patients without T2DM. Compared with the IR group, miR‑93‑5p overexpression significantly increased cell proliferation, glucose consumption and glycogen synthesis, but significantly inhibited apoptosis in insulin‑resistant HepG2 cells. By contrast, compared with the IR group, HGF overexpression significantly inhibited cell proliferation, glucose consumption and glycogen synthesis, but significantly enhanced cell apoptosis in insulin‑resistant HepG2 cells. Following co‑transfection with HGF overexpression vector and miR‑93‑5p mimic, miR‑93‑5p mimic‑mediated induction of HepG2 cell proliferation, glucose consumption and glycogen synthesis in insulin‑resistant HepG2 cells was inhibited. Collectively, the results of the present study indicated that miR‑93‑5p enhanced insulin resistance to regulate T2DM progression in HepG2 cells by targeting HGF.
Insights
MicroRNA-93-5p enhances insulin resistance in type 2 diabetes by targeting hepatocyte growth factor in liver cells. This finding provides new insights into T2DM mechanisms and potential therapeutic targets.
Area of Science:
- Molecular Biology
- Endocrinology
- Cell Biology
Background:
- Insulin resistance is a key feature of type 2 diabetes mellitus (T2DM), but its underlying mechanisms remain incompletely understood.
- MicroRNAs (miRNAs) play crucial roles in regulating cellular processes, including metabolism and disease pathogenesis.
Purpose of the Study:
- To investigate the role of microRNA (miR)-93-5p in the development of insulin resistance in T2DM.
- To elucidate the molecular mechanism by which miR-93-5p influences insulin resistance in hepatocellular carcinoma (HepG2) cells.
Main Methods:
- Established an in vitro insulin-resistant HepG2 cell model using high glucose conditions.
- Assessed glucose consumption, glycogen synthesis, cell viability, proliferation, and apoptosis.
- Quantified miR-93-5p and hepatocyte growth factor (HGF) expression, and investigated their interaction using RT-qPCR, western blotting, and dual-luciferase reporter assays.
Main Results:
- miR-93-5p expression was significantly increased, while HGF expression was decreased in T2DM liver tissues and insulin-resistant HepG2 cells.
- Overexpression of miR-93-5p enhanced proliferation, glucose consumption, and glycogen synthesis, while inhibiting apoptosis in insulin-resistant HepG2 cells.
- HGF overexpression exhibited opposite effects, and miR-93-5p's effects were partially abrogated by HGF co-expression, indicating HGF as a target.
Conclusions:
- miR-93-5p exacerbates insulin resistance in HepG2 cells by targeting and downregulating HGF.
- This miR-93-5p/HGF axis represents a potential regulatory pathway in T2DM progression.
- Findings suggest miR-93-5p as a potential therapeutic target for managing insulin resistance in T2DM.
More Related Videos
Related Concept Videos
Cell Specific Gene Expression
Insulin: The Receptor and Signaling Pathways
Abnormal Proliferation

